Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/1999
03/10/1999CN1209995A The use of inhibitors of sodium-hydrogen exchanger for production of medicaement for decreaing undesired effects of substances on heart
03/10/1999CN1209994A Use of inhibitors of sodium-hyfrogen exchanger for production of pharmaceutical for treatment of disorders which are caused by protozoa
03/10/1999CN1042430C N-alkyl-2-substituted ATP anologues, preparation and use thereof
03/10/1999CN1042429C 5-(1-fluoro-vinyl-1H-pyrimidine-2,4-dione derivatives, medicinal composition and preparation thereof
03/10/1999CN1042428C Preparation of 1-N-ethylsisomicin
03/10/1999CN1042425C 3-hydroxy-4-hydroxymethyl-2-methylenecyclopentyl purines and pyrimidines
03/10/1999CN1042424C Process for converting loracarbef dihydrate to loracarbef monohydrate
03/10/1999CN1042423C Ameilazole salt hydrate for gastric acid inhibitor and its preparation
03/10/1999CN1042421C Preparation of acridine derivatives
03/10/1999CN1042394C Pharmaceutical composition containing felbinac
03/10/1999CA2243670A1 Novel histidine kinase
03/09/1999US5880284 Cyclic urea derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
03/09/1999US5880283 8-alkoxyquinolonecarboxylic acid hydrate with excellent stability and process for producing the same
03/09/1999US5880280 Aryl, alkyl, alkenyl and alkynylmacrolides having immunosuppressive activity
03/09/1999US5880208 Polymer compounds
03/09/1999US5880163 Oil composition of dihydropolyprenols
03/09/1999US5880160 Antiproliferative, antineoplastic, antiinflammatory and muscle relaxant activities
03/09/1999US5880159 Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
03/09/1999US5880156 Antiarrhythmia agents
03/09/1999US5880155 Treatment of cardiovascular disorders
03/09/1999US5880152 Inflammatory bowel disease
03/09/1999US5880151 Treating or preventing disease characterized by high levels of low density lipoprotein particles or cholesterol in blood
03/09/1999US5880149 Metal complexes as cysteine protease inhibitors
03/09/1999US5880148 Treating diabetes, arterial hypertension, restenosis and atheromatous diseases
03/09/1999US5880147 Amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prohylactic use
03/09/1999US5880146 Inhibition of IL-12-induced IFN-γ synthesis by specific bis-phenol compounds as a method of immune modulation
03/09/1999US5880144 Pharmaceutical composition for inhibiting the growth of viruses and cancers comprising thiabendazole
03/09/1999US5880141 Controlling, modulating and inhibiting tyrosine kinase signal transduction
03/09/1999US5880136 Sulfonamide fibrinogen receptor antagonists
03/09/1999US5880135 Antagonist activity with respect to corticotropin releasing hormone
03/09/1999US5880134 Method for using ergoline compounds to effect physiological and pathological functions at the 5-HT7 receptor
03/09/1999US5880133 Mixture containing n-methylpyrrolidone and an acid excipient
03/09/1999US5880132 Tachykinin antagonist and an opioid analgesic effective at treating pain or nociception
03/09/1999US5880131 Polyoxyalkylene derivatives
03/09/1999US5880130 Treatment of cell-proliferation diseases
03/09/1999US5880129 Methods of inhibiting invasion and metastasis of malignant solid tumors
03/09/1999US5880126 9H-Pyridu ((3,4-b) indole derivatives
03/09/1999US5880124 For treatment of hypotension
03/09/1999US5880123 Hemolysis prevention by non-ionic surfactants
03/09/1999US5880120 Treating depression by administering an antidepressant
03/09/1999US5880117 Use of 4-androstenediol to increase testosterone levels in humans
03/09/1999US5880116 Use of celastrol to treat alzheimer's disease
03/09/1999US5880115 Steroid sulfatase inhibitors and methods for making and using the same
03/09/1999US5880114 Treatment of immune deficiency with vitamin D compounds
03/09/1999US5880113 Antiproliferative agents, cell differentiation inducers
03/09/1999US5880109 Method of accelerating intestinal absorption of calcium in mammals
03/09/1999US5880108 Cystitis
03/09/1999US5880107 Sodium hyaluronate based ophthalmic formulation for use in eye surgery
03/09/1999US5880106 Containing water insoluble antacid buffering composition combined with dihydroxyaluminum alkali metal carbonate or calcium carbonate, optional excipients; improved bioavailability, reduced side effects
03/09/1999US5880100 Method for inhibiting binding of human lens cells
03/09/1999US5880098 Administering an organic osmolyte selected from polyols, amino acids and methyl amines
03/09/1999US5880097 Tethered prodrugs
03/09/1999US5879908 CRFG-1a, a target and marker for chronic renal failure
03/09/1999US5879893 Hybridization method for detecting polynucleotides coding for signal transduction inhibitor protein in body fluids and tissue samples; treatment of alzheimer's disease and cancer
03/09/1999US5879892 Relates to nucleic acid molecules and encoded polypeptides which are expressed preferentially in leukemia.
03/09/1999US5879877 Separating motile sperm
03/09/1999US5879711 Stable antiandrogenic gel composition
03/09/1999US5879710 Comprising melatonin and melatonin derivatives, acrylic acid polymeric resin, magnesium stearate, lactose diluent, polyvinylpyrrolidinone and cellulose derivatives
03/09/1999US5879708 Stabilized pharmaceutical composition
03/09/1999US5879706 Valaciclovir tablets containing colloidal silicon dioxide
03/09/1999US5879705 Analgesics for administering twice a day
03/09/1999US5879702 Analgesic anti-inflammatory adhesive preparations
03/09/1999US5879701 Transdermal delivery of basic drugs using nonpolar adhesive systems and acidic solubilizing agents
03/09/1999US5879700 Treating herpes virus infections
03/09/1999US5879698 Calcium dietary supplement
03/09/1999US5879692 Tocopheryl ascorbyl phosphate-cyclodextrin clathrate and a topical dermal composition containing said clathrate
03/09/1999US5879690 Increasing muscle tone in subcutaneous muscle tissue
03/09/1999US5879688 Treatment of skin disorders, wrinkling, aging
03/09/1999US5879683 Antibacterial agent containing tea extract or active fraction thereof and β-lactam antibiotic
03/09/1999US5879673 Administration of thrombopoietin on a single day only
03/09/1999US5879665 Extract of johimbe tree bark and topical vehicle or carrier
03/09/1999US5878750 Method of treating the syndrome of coronary heart disease risk factors in humans
03/09/1999US5878747 Condom coated with acidic polysaccharides
03/09/1999CA2243656A1 Response regulator
03/09/1999CA2148823C Sustained release microsphere preparation containing antipsychotic drug and production process thereof
03/09/1999CA2131831C The use of quinoline-3-carboxamide compounds for treatment of diabetes
03/09/1999CA2059403C Use of carrageenans in topical ophthalmic compositions
03/09/1999CA2002761C Adhesive tape preparation of clonidine
03/09/1999CA1340430C Preparation of antihypercholesterolemic tetrazole compounds and intermediates thereof
03/09/1999CA1340424C Substituted vinylcephalosporins, processes for their preparation and their use as medicaments
03/09/1999CA1340422C Anthracycline derivatives having cytostatic activity
03/08/1999CA2242476A1 Novel compositions containing cyclosporin
03/05/1999CA2212237A1 Novel antineoplastic agents
03/04/1999WO1999010525A1 A method of treating cancer
03/04/1999WO1999010524A1 A method of treating cancer
03/04/1999WO1999010523A1 A method of treating cancer
03/04/1999WO1999010519A1 Process for preparing enantiomerically enriched n-derivatised lactams
03/04/1999WO1999010502A1 Human nucleotide pyrophosphohydrolase
03/04/1999WO1999010499A1 Statin production by fermentation
03/04/1999WO1999010494A2 Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses
03/04/1999WO1999010486A2 Mdm2-specific antisense oligonucleotides
03/04/1999WO1999010480A2 New tissue-specific calpaines, their production and their use
03/04/1999WO1999010360A1 Oligosaccharide derivatives and process for producing the same
03/04/1999WO1999010349A1 Oxindolylquinazoline derivatives as angiogenesis inhibitors
03/04/1999WO1999010348A1 Optionally protected 3-hydroxymethyl carbapenems and synthesis
03/04/1999WO1999010347A1 Substituted 4-oxo-napthyridine-3-carboxamides as gaba brain receptor ligands
03/04/1999WO1999010346A1 Benzothiadiazinyl-indole derivatives and their use as serotonin receptor ligands
03/04/1999WO1999010345A1 Method for preventing or treating erectile dysfunction by administering an endothelin antagonist
03/04/1999WO1999010344A1 Indole derivatives as 5-ht1b and 5-ht1d agonists
03/04/1999WO1999010343A1 Oxazolidinone derivatives and their use as antibacterial agents
1 ... 6530 6531 6532 6533 6534 6535 6536 6537 6538 6539 6540 6541 6542 6543 6544 6545 6546 6547 6548 6549 6550 ... 7860